Wednesday, february 26, 2020 tagFinancial results

Half-year results at the end of December 2019

  • SHARE ON
  • twitter
  • facebook
  • linkedin

Satisfactory results which confirm our integrated care strategy and our leadership position in Europe

Ramsay Santé
  • Half year reported turnover up 44.4% to EUR 1,934.5 million. At constant scope and exchange rates, solid growth (+3.0%);
  • Very strong increase in EBITDA reported under new IFRS accounting standards to EUR 272.9 million. Good improvement in EBITDA margin at constant scope, exchange rate and accounting standards;
  • Group net profit at break-even under new IFRS accounting standards but positive at EUR 11.4 million excluding the dilutive impact of IFRS 16;
  • Integration process of Capio very well advanced, financial and strategic perspectives above expectations;
  • Acceleration of the digitalization of the Group and continuous transformation of our organizations in order to achieve efficiency and improve our care pathways.
The prospects that had been opened a bit more than one year ago with the acquisition of Capio have been confirmed and allow us to display, at constant perimeter, conversion rate and accounting standards, an increase of revenue of +3%, as well as a solid improvement of our operational margin. Hence, the diversity and the complementarity of our businesses and our geographies in Europe make us very confident for the future. This future, we have continued to prepare it through a high level of investment, focused on care quality for our patients and attractiveness towards doctors.

Pascal Roché, CEO of Ramsay Santé

The Board of Directors, meeting on 24 February, approved the consolidated financial statements for the semester ended December 2019. The accounts were subject to a limited review by the statutory auditors.

In EUR million from 1 July 2019
to 31 December 2019
 Change from 1 July 2018
to 31 December 2018
Turnover 1 934.5+44.4%1 340.1
EBITDA272.8+121.7%123.1
Current operating profit94.1+92.4%48.9
As a % of turnover4.9%+1.3 point3.6%
Operating Profit89.2+155.6%34.9
Net income - Group share
0.0--0.0
Net Earnings per Share (EUR)0.00 0.00

 

In EUR million  from 1 July 2019
to 31 December 2019
from 1 July 2018
to 31 December 2018
Change 
 Ile de France453.5446.2+1.6%
 Auvergne Rhône Alpes190.9180.7+5.6%
 Nord – Pas de Calais - Picardie187.0180.3+3.7%
 Provence Alpes Côte d’Azur79.175.7+4.5%
 Bourgogne Franche Comté53.352.1+2.3%
 Other regions160.9153.7+4.7%
 Other activities4.04.2-4.8%
 Capio805.8247.2+226.0%
 Published turnover1 934.51 340.1+44.4%
 Of which:
- At constant scope and exchange rates
1 366.81 327.0+3.0%
- Changes in scope and exchange rates567.713.1 nm


Significant events during the half year :


Following the acquisition of Capio on 7 November 2018, the appraisal of identifiable assets and liabilities acquired at their fair value at the date of acquisition have been finalized over the semester. The goodwill related to the Capio acquisition amounts to EUR 950,0 million.

On 1 December 2019, activities of Clinique Jeanne d’Arc in Gien (Centre-Val de Loire) were transfered to the Centre Hospitalier régional d’Orléans (CHRO).


Operations and turnover :


During the half year ending on 31 December 2019, the Ramsay Santé Group reported consolidated turnover of EUR 1,934.5 million, compared with EUR 1,340.1 million from 1 July 2018 to 31 December 2018, up 44.4%.

At constant scope of perimeter and exchange rates, the Group's turnover increased by a strong 3.0% to EUR 1,366.8 million over the semester.

Changes in the scope of consolidation are almost entirely explained by the consolidation of the Capio Group as from 7 November 2018. It contributed to an incremental EUR 558.6 million to the Group's consolidated turnover over this half year.

At the end of December 2019, the total activity of the French entities of Ramsay Santé, excluding Capio, increased by 2.7% in terms of the volume of admissions (excluding emergencies). The breakdown by business segment is as follows:

  • +0.9% in Medicine-Surgery-Obstetrics
  • +9.8% in sub-acute care and rehabilitation
  • +3.3% in mental health
With regard to the public service tasks managed by the group, the number of emergencies increased, up 4.7% over the last half year with more than 316,000 cases registered by the emergency services at our facilities.

In addition, organic growth of nordics activities is up 4,6% for the half year ended 31 December 2019, compared to the same period in 2018.

Results :


EBITDA for the half year ended 30 December 2019 was EUR 272.9 million, up 121.7% on a reported basis. The implementation of the new IFRS 16 accounting standard from 1 July 2019 improves the Group EBITDA by EUR 99.2 million. Using the same scope, exchange rates and accounting methods, the EBITDA margin as a percentage of turnover increased significantly to reach 10.4% over the 6 months.

Reported current operating profit for the period 1 July 2019 to 31 December 2019 reached EUR 94.1 million (or 4.9% of turnover), up 92.4% from compared to EUR 48.9 million booked over the semester ended 31 December 2018. The implementation of the new IFRS 16 accounting standard improved the Group current operating profit by EUR 18.2 million.

The amount of other non-current income and expenses represents a net expense of EUR 4.9 million for the period ended 31 December 2019, consisting mostly of costs related to the integration of the Capio Group as well as to the restructuring project of our Marseille facilities. From 1 July 2018 to 31 December 2018, the amount of other non-current income and expenses represented a net expense of EUR 14.0 million.

At 31 December 2019, the net cost of borrowing amounted to EUR 30.1 million, compared with EUR 27.6 million the first semester of the previous year. This consists primarily of interest on senior debt. Through the implementation of the IFRS 16 accounting standard, the Group booked, in addition, financial expenses related to the the new rental debt amounting to EUR 35.7 million.

In total, Group net profit as at 31 December 2019 is at break-even, encompassing the dilutive EUR 11.4 million impact of IFRS 16.


Debt :


Net financial debt at 31 December 2019 increased significantly as a result of the first implementation of IFRS 16 to reach EUR 3,682.1 million compared to EUR 2 252.5 million at 31 December 2018. This debt includes, in particular, EUR 3,719.3 million in non-current borrowings and financial debt, EUR 205.0 million in current financial debt, offset by EUR 226.3 million in closing cash position.

The implementation of the IFRS 16 accounting standard to operarting leases implied a EUR 1,953.1 million increase of the net financial debt at 31 December 2019 of which EUR 1,817.6 million of non-current rental debt and EUR 135.5 million of current rental debt.


ISIN and Euronext Paris code: FR0000044471
Website: www.ramsaygds.com

CONFERENCE CALL TODAY IN ENGLISH
At 7 :00 pm (Paris time) – Please dial in


from France:  +33 (0)1 76 77 22 61
from the UK:  +44 (0)330 336 6025
from Australia:  +61 (0)2 8524 5352

Access code: 465602

About Ramsay Santé

After the acquisition of the Capio Group in 2018, Ramsay Santé has become the leading European provider of comprehensive healthcare services. The group now has 36,000 employees and works with nearly 8,600 private practitioners.

Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments.

In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres.

The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS).

The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.

Wednesday, february 26, 2020 tagFinancial results
  • SHARE ON
  • twitter
  • facebook
  • linkedin
Quotes
Contact
  • Brigitte Cachon
  • Director of Communication, Brand & CSR
  • +33 (0)1 87 86 22 11
Related News
  • Wednesday, october 20, 2021
    Final annual results at the end of June 2021 [View press release]
  • Tuesday, september 21, 2021
    Date of approval of the final consolidated financial statements for the year ending June 2021 [View press release]
  • Wednesday, august 25, 2021
    Provisional annual results at the end of June 2021 [View press release]
  • Wednesday, february 24, 2021
    Half-year results at the end of December 2020 [View press release]
  • Tuesday, october 20, 2020
    Annual results at the end of June 2020 [View press release]
View all releases